Dein Go-to-Market-Plan
Mit welcher Kundengruppe du startest, über welche Kanäle und mit welchem Budget.
Medical device, biotech, food or agritech: planix plans around the long paths of these industries – starting segment, direct access to decision-makers, pilot and a roadmap that is realistic.
Starting segment, access to decision-makers, pilot – with a realistic roadmap.
Included in Premium. Develop go-to-market comes with the subscription from CHF 24 per month. The strategy with lead list and messages costs CHF 49 one-off, no subscription needed.
Approvals, supplier qualification and test series make every sale longer. That’s why, for pharma and medtech, the module plans over twelve months instead of twelve weeks. In food and agriculture, samples and pilot batches count: a buyer purchases what they have tested in their own production.
Approvals, supplier qualification and test series make every sale longer. That’s why, for pharma and medtech, the module plans over twelve months instead of twelve weeks.
Businesses that need to replace an ingredient, process or product – and can get it delivered within three months.
Comes next: volume, but listing processes and long lead times.
Too broad: buyers, approval and payers differ by submarket.
Market figures from: Swiss Federal Statistical Office (STATENT), Zefix, SHAB, Eurostat, OpenStreetMap, OpenHolidays
For medtech, a pilot of four to eight weeks; for food and agriculture, typically a sample delivery. Always with a fixed scope, full price afterwards and a reference as the condition. If you choose yourself, your choice takes priority.
For medtech, a pilot of four to eight weeks; for food and agriculture, typically a sample delivery.
The plan is included in Premium. For long decision paths, the strategy for CHF 49 pays off: buyer roles with decision timing, lead list with trigger and link, pilot offer and call guide.
The plan is included in Premium. For long decision paths, the strategy for CHF 49 pays off: buyer roles with decision timing, lead list with trigger and link, pilot offer and call guide.
See pricingIn pharma and medtech, approvals and purchasing processes take longer. The module plans over twelve months there so the roadmap stays realistic.
No. Delivery readiness is a mandatory criterion of the starting segment – you state whether a product is approved. Regulatory checks are not part of this module.
Backed by leading start-up experts and partners


Develop go-to-market shows you who to start with – in Premium, in a few minutes.
Get started In Premium · from CHF 24/month · Go-to-market strategy CHF 49 one-off, no subscription needed